These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 7533136

  • 1. Modulation of lipopolysaccharide binding to human granulocytes.
    Weersink AJ, Van Kessel KP, Van der Tol ME, Verhoef J.
    Immunology; 1994 Dec; 83(4):617-23. PubMed ID: 7533136
    [Abstract] [Full Text] [Related]

  • 2. Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14.
    Corrales I, Weersink AJ, Verhoef J, van Kessel KP.
    Immunology; 1993 Sep; 80(1):84-9. PubMed ID: 7503949
    [Abstract] [Full Text] [Related]

  • 3. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
    Weersink AJ, van Kessel KP, van den Tol ME, van Strijp JA, Torensma R, Verhoef J, Elsbach P, Weiss J.
    J Immunol; 1993 Jan 01; 150(1):253-63. PubMed ID: 7678030
    [Abstract] [Full Text] [Related]

  • 4. Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists.
    Lynn WA, Raetz CR, Qureshi N, Golenbock DT.
    J Immunol; 1991 Nov 01; 147(9):3072-9. PubMed ID: 1717586
    [Abstract] [Full Text] [Related]

  • 5. Binding of rough lipopolysaccharides (LPS) to human leukocytes. Inhibition by anti-LPS monoclonal antibody.
    Weersink AJ, Van Kessel KP, Torensma R, Van Strijp JA, Verhoef J.
    J Immunol; 1990 Jul 01; 145(1):318-24. PubMed ID: 2162891
    [Abstract] [Full Text] [Related]

  • 6. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes.
    Blondin C, Le Dur A, Cholley B, Caroff M, Haeffner-Cavaillon N.
    Eur J Immunol; 1997 Dec 01; 27(12):3303-9. PubMed ID: 9464818
    [Abstract] [Full Text] [Related]

  • 7. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
    de Haas CJ, van der Tol ME, Van Kessel KP, Verhoef J, Van Strijp JA.
    J Immunol; 1998 Oct 01; 161(7):3607-15. PubMed ID: 9759883
    [Abstract] [Full Text] [Related]

  • 8. Binding, internalization, and deacylation of bacterial lipopolysaccharide by human neutrophils.
    Luchi M, Munford RS.
    J Immunol; 1993 Jul 15; 151(2):959-69. PubMed ID: 7687625
    [Abstract] [Full Text] [Related]

  • 9. Diverging pathways for lipopolysaccharide and CD14 in human monocytes.
    Antal-Szalmás P, Poppelier MJ, Broekhuizen R, Verhoef J, van Strijp JA, van Kessel KP.
    Cytometry; 2000 Dec 01; 41(4):279-88. PubMed ID: 11084613
    [Abstract] [Full Text] [Related]

  • 10. Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function.
    Grunwald U, Krüger C, Schütt C.
    Circ Shock; 1993 Mar 01; 39(3):220-5. PubMed ID: 7680967
    [Abstract] [Full Text] [Related]

  • 11. Functional analysis of recombinant bovine CD14.
    Wang Y, Zarlenga DS, Paape MJ, Dahl GE, Tomita GM.
    Vet Res; 2003 Mar 01; 34(4):413-21. PubMed ID: 12911858
    [Abstract] [Full Text] [Related]

  • 12. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.
    Troelstra A, de Graaf-Miltenburg LA, van Bommel T, Verhoef J, Van Kessel KP, Van Strijp JA.
    J Immunol; 1999 Apr 01; 162(7):4220-5. PubMed ID: 10201950
    [Abstract] [Full Text] [Related]

  • 13. CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis.
    Labeta MO, Durieux JJ, Spagnoli G, Fernandez N, Wijdenes J, Herrmann R.
    Immunology; 1993 Nov 01; 80(3):415-23. PubMed ID: 7507090
    [Abstract] [Full Text] [Related]

  • 14. Accelerated internalization and detoxification of endotoxin by anti-lipopolysaccharide antibody is an Fc receptor--mediated process.
    Lazaron V, Leslie DB, Wasiluk KR, Dunn DL.
    Surgery; 2001 Aug 01; 130(2):192-7. PubMed ID: 11490348
    [Abstract] [Full Text] [Related]

  • 15. Variation of LPS-binding capacity, epitope expression, and shedding of membrane-bound CD14 during differentiation of human monocytes.
    Pedron T, Girard R, Chaby R.
    J Immunol; 1995 Aug 01; 155(3):1460-71. PubMed ID: 7543522
    [Abstract] [Full Text] [Related]

  • 16. Moesin: a potential LPS receptor on human monocytes.
    Amar S, Oyaisu K, Li L, Van Dyke T.
    J Endotoxin Res; 2001 Aug 01; 7(4):281-6. PubMed ID: 11717582
    [Abstract] [Full Text] [Related]

  • 17. Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations.
    Antal-Szalmás P, Poppelier MJ, Sümegi A, van der Bruggen T, Verhoef J, van Kessel KP, van Strijp JA.
    Immunol Lett; 2004 Apr 30; 93(1):11-5. PubMed ID: 15134893
    [Abstract] [Full Text] [Related]

  • 18. Anti-CD14 antibodies reduce responses of cultured human endothelial cells to endotoxin.
    von Asmuth EJ, Dentener MA, Bazil V, Bouma MG, Leeuwenberg JF, Buurman WA.
    Immunology; 1993 Sep 30; 80(1):78-83. PubMed ID: 7503948
    [Abstract] [Full Text] [Related]

  • 19. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes.
    Gallay P, Jongeneel CV, Barras C, Burnier M, Baumgartner JD, Glauser MP, Heumann D.
    J Immunol; 1993 Jun 01; 150(11):5086-93. PubMed ID: 7684419
    [Abstract] [Full Text] [Related]

  • 20. Shedding of sCD14 by bovine neutrophils following activation with bacterial lipopolysaccharide results in down-regulation of IL-8.
    Sohn EJ, Paape MJ, Bannerman DD, Connor EE, Fetterer RH, Peters RR.
    Vet Res; 2007 Jun 01; 38(1):95-108. PubMed ID: 17156740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.